- SteinCares enters Mexico—one of the most strategic pharmaceutical markets in Latin America—to expand its footprint and accelerate growth across the region.
- The partnership marks a major milestone in SteinCares’ regional expansion, underscoring its commitment to creating healthcare opportunities across the region.
San Jose, Costa Rica, July 28, 2025. SteinCares, a leading specialty healthcare company in Latin America operating in over 30 countries, today announced its official entry into the Mexican market through a strategic joint venture with Laboratorios Carnot, a leading Mexican pharmaceutical company with more than 80 years of experience in the country.
This collaboration combines SteinCares’ extensive experience in licensing and commercializing specialty healthcare products throughout Latin America with Carnot’s deep knowledge of the Mexican healthcare ecosystem. Carnot brings proven capabilities in regulatory affairs, market access, and commercial execution, providing a solid foundation for local operations.
Designed to evolve into an independent structure, the joint venture will leverage the strengths, expertise, and capabilities of both organizations. This synergy enables a more agile, efficient, and locally tailored approach to expanding access to specialty care in Mexico.
Mexico represents approximately 20% of the Latin American pharmaceutical market, making it a cornerstone in SteinCares’ strategy to consolidate its presence and expand its reach across the region. With the recent entry into Brazil, this move further strengthens SteinCares’ geographic footprint and positions the company as a leading platform for specialty healthcare in Latin America.
“This joint venture with Carnot marks a pivotal moment in our journey to deepen our presence across Latin America,” said Mitchell Waserstein, CEO of SteinCares. “By combining our one-stop-shop platform with Carnot’s experience and deep local knowledge, we are poised to make a meaningful difference in access to innovative and cost-effective treatments for Mexicans.”
This joint venture brings together a regional perspective and local expertise—an alliance that will help close access gaps and deliver innovative, high-quality treatments. Together, SteinCares and Carnot are building a collaborative platform that prioritizes access, blends complementary strengths, and reflects a shared purpose: to create healthcare opportunities for Mexicans.
About SteinCares
SteinCares is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars, plasma-derived therapies and complex generics. With 45 years of progressive healthcare experience and operations in over 30 countries in Latin America and the Caribbean, SteinCares serves as a bridge between global pharmaceutical companies and the region’s healthcare providers. The company is deeply committed to creating healthcare opportunities that positively impact the lives of patients and their families in Latin America, with a vision of increasing access to innovative and cost-effective healthcare for patients in the region.
For more information, visit http://www.steincares.com/ or follow the company on LinkedIn.
About Carnot Laboratorios
Founded in 1941 with the mission of developing pharmaceutical products, Carnot Laboratorios established processes of excellence from its inception. By attracting talented individuals, the company built a foundation for success based on its strength, values, and adaptability over more than seven decades. With extensive experience exporting pharmaceutical products throughout Latin America, Carnot Laboratorios develops innovative products for licensing in international markets, making it an ideal partner for registering, promoting, and selling products in Latin America with the highest standards of quality, regulatory compliance, and ethics.
For more information, visit https://www.carnot.com/
